BI 1819479 clinical trials
Also written BI 1819479.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2021
How each study uses BI 1819479 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- BI 1819479
- 6
Studies by the year they started
6 studies that test it; most in 2022 (3)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Studies
Open first, then newest update. How each study uses BI 1819479 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Study to Test How BI 1819479 is Taken up and Processed by the BodyTerminatedPhase 1Boehringer IngelheimNCT07065617Written as [14C]BI 1819479
- A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)CompletedPhase 2Boehringer IngelheimNCT06335303Written as BI 1819479
- A Study to Test How Healthy Women Tolerate Different Doses of BI 1819479CompletedPhase 1Boehringer IngelheimNCT05440799Written as BI 1819479
- A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are ToleratedCompletedPhase 1Boehringer IngelheimNCT05469646Written as BI 1819479
- A Study in Healthy Men to Test How Esomeprazole Influences the Amount of BI 1819479 in the BloodCompletedPhase 1Boehringer IngelheimNCT05467475Written as BI 1819479
- A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated and Taken up by the Body With or Without FoodCompletedPhase 1Boehringer IngelheimNCT04801693Written as BI 1819479